Tamsulosin Hydrochloride
Product Images NDC 73750-099

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 73750-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qyk Brands Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

73750 099 Copy

73750 099 Copy
This is a prescription medication called Tamsulosin Hydrochloride Capsules, USP with a dosage of 0.4mg per capsule. It comes in a container with 100 capsules and should be stored at a temperature range of 20°C-25°C (68°F-77°F), with excursions permitted to 15°C-30°C (59°F-86°F). Excessive moisture should be avoided, and it should be dispensed in an airtight container. It is distributed by QYK Brands in Garden Grove, CA, with a revision date of 01/2022. The package insert should be read before administering, and it is important to keep it out of the reach of children. The product has an NDC number of 73750-099-10.*
FDA Label Image

Figure 1 mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n = 8) (Figure 1)

Figure 1 mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n = 8) (Figure 1)
FDA Label Image

Figure 2a mean Change From Baseline In Total Aua Symptom Score (0-35) Study 1 (Figure 2 A)

Figure 2a mean Change From Baseline In Total Aua Symptom Score (0-35) Study 1 (Figure 2 A)
FDA Label Image

Figure 2b mean Change From Baseline In Total Aua Symptom Score (0-35) Study 2 (Figure 2 B)

Figure 2b mean Change From Baseline In Total Aua Symptom Score (0-35) Study 2 (Figure 2 B)
FDA Label Image

Figure 3a mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Figure 3 A)

Figure 3a mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Figure 3 A)
FDA Label Image

Figure 3b mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Figure 3 B)

Figure 3b mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Figure 3 B)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.